Seminars may increase recruitment to randomised controlled trials: lessons learned from WISDOM

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

JAMA · 2002 · 15.7K citations · Full text

Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. Writing Group for the Women's Health Initiative Investigators. <i>JAMA</i> 2002; 288(3): 321-333

Dr Ailsa Gebbie · Journal of Family Planning and Reproductive Health Care · 2002 · 1.2K citations · Full text

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women

Madge Vickers, Alastair H. MacLennan, Beverley Lawton et al. · BMJ · 2007 · 246 citations · Full text

Improving Accrual of Older Persons to Cancer Treatment Trials: A Randomized Trial Comparing an Educational Intervention With Standard Information: CALGB 360001

Gretchen Kimmick, Bercedis L. Peterson, Alice B. Kornblith et al. · Journal of Clinical Oncology · 2005 · 127 citations · Full text

The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial

Madge Vickers, Jeannett Martin, Tom Meade · BMC Women s Health · 2007 · 54 citations · Full text